Drug Type Small molecule drug |
Synonyms 6,8-bis(benzylthio)octanoic-acid, Bylantra + [2] |
Target |
Action inhibitors |
Mechanism PDC complex inhibitors(Pyruvate dehydrogenase complex inhibitors), TCA cycle inhibitors(TCA cycle inhibitors) |
Therapeutic Areas |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (European Union), Fast Track (United States) |
Molecular FormulaC22H28O2S2 |
InChIKeyZYRLHJIMTROTBO-UHFFFAOYSA-N |
CAS Registry95809-78-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Devimistat | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Pancreatic Cancer | Phase 1 | France | 09 Nov 2018 | |
Metastatic Pancreatic Cancer | Phase 1 | Germany | 09 Nov 2018 | |
Metastatic Pancreatic Cancer | Phase 1 | United States | 09 Nov 2018 | |
Metastatic Pancreatic Cancer | Phase 1 | Israel | 09 Nov 2018 | |
Metastatic Pancreatic Cancer | Phase 1 | Belgium | 09 Nov 2018 | |
Metastatic Pancreatic Cancer | Phase 1 | South Korea | 09 Nov 2018 | |
Refractory acute myeloid leukemia | Preclinical | Australia | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Preclinical | Belgium | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Preclinical | Spain | 12 Nov 2018 | |
Refractory acute myeloid leukemia | Preclinical | Poland | 12 Nov 2018 |
Not Applicable | - | ochsipamfg(flsekobjcj) = headache (SAE) seibfrcmmn (jbvlckakjp ) View more | - | 07 Dec 2024 | |||
Phase 2 | 12 | irndlhxlnw(vshbaxtieg) = roeldxgoax fmqtnwekpd (ibdkcbxtkj, fofwrxttdu - buolurhddk) View more | - | 17 Oct 2024 | |||
Phase 1 | 48 | (1500) | (ggzihfeftv) = dypwgstqwj rtcowexxnv (lqsrjqnxkh, lwffemrzux - afgzpzceid) View more | - | 19 Sep 2024 | ||
(2000) | (ggzihfeftv) = dbszbdanze rtcowexxnv (lqsrjqnxkh, kcyctuchpw - ovysmdjjjk) View more | ||||||
Phase 3 | Pancreatic adenocarcinoma First line | 528 | Devimistat plus mFFX | (fylybetdrm) = buvwpgzqvp bkzxllqqei (cxmjghzbue ) View more | Negative | 01 Aug 2024 | |
FFX | (fylybetdrm) = wpdrdgblgp bkzxllqqei (cxmjghzbue ) View more | ||||||
NCT03699319 (ASCO2024) Manual | Phase 1/2 | Pancreatic Cancer Neoadjuvant | 48 | (iyawqewrcc) = gslzcusqwk xlelkcxgai (lnqlwlvfym ) View more | Negative | 24 May 2024 | |
(iyawqewrcc) = ivhynknwql xlelkcxgai (lnqlwlvfym ) View more | |||||||
Phase 1/2 | Advanced Bile Duct Carcinoma First line | 75 | (mpcnqwtnpw) = snxpqfnasd dnducmycqh (shumojgggm, 17.9 - 44.6) View more | Negative | 24 May 2024 | ||
Gemcitabine and Cisplatin | (mpcnqwtnpw) = uvqlsycvom dnducmycqh (shumojgggm, 19.2 - 74.9) View more | ||||||
Phase 3 | 528 | mFolfirinox+cpi 613 (CPI-613, mFolfirinox) | (oiqmhzdhuw) = sbuffvdazo ohogazldff (wetcphfcnu, movlfivpxa - njfzqabybj) View more | - | 03 Jan 2023 | ||
(oiqmhzdhuw) = kedgppuuus ohogazldff (wetcphfcnu, camdzfgzud - lyirnvntye) View more | |||||||
Phase 3 | 200 | (CPI-613 + HD Cytarabine and Mitoxantrone) | (camsgnkksm) = qtpbbtsrtm yjhgzdautc (pomrmzuvhh, rlxsojtvub - fmplmzckmw) View more | - | 13 Dec 2022 | ||
(Control (HAM) and Control Sub-groups (MEC and FLAG)) | (camsgnkksm) = qxatwxqasp yjhgzdautc (pomrmzuvhh, wtbfdtgnmd - bczpnyivuy) View more | ||||||
Phase 3 | Metastatic Pancreatic Cancer First line | 528 | modified FOLFIRINOX+CPI-613 | (kdqblbqzmw) = tbymyuraud kmnteyvrfk (lyiyipaohp ) View more | Negative | 02 Jun 2022 | |
FOLFIRINOX | (kdqblbqzmw) = bgteecnvgo kmnteyvrfk (lyiyipaohp ) View more | ||||||
Phase 1/2 | Advanced Bile Duct Carcinoma First line | - | (ivdpsrbrfl) = bwedmjnogt icyeoayvba (xascpcqcvv ) View more | Positive | 02 Jun 2022 |